CMS is proposing a coverage pathway to achieve expedited and more predictable access to new medical technologies for Medicare beneficiaries.Read More »
CMS recently released a list of the 43 Part B drugs and biologicals that will be included in the Medicare Prescription Drug Inflation Rebate Program for July 1–September 30.Read More »
NAHRI members learned about the latest association news, tips for managing the unwinding of COVID-19 public health emergency (PHE) waivers, and more on the April 25 NAHRI Quarterly Call.Read More »
Use these charts to identify extensions and end dates for COVID-19 public health emergency (PHE) waivers and flexibilities and effected services in hospitals, CAHs, RHCs, FQHCs, and physician services.Read More »